7 results match your criteria: "Yazd Azad University[Affiliation]"
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
December 2022
Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
September 2022
Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Background: Breast cancer is the most frequently diagnosed cancer and the leading reason for cancer-related death among women. Neoadjuvant treatment with dual-HER2 (human epidermal growth factor receptor 2) blockade has shown promising effects in this regard. The present study aimed to compare the efficacy and safety of a proposed pertuzumab biosimilar with the reference pertuzumab.
View Article and Find Full Text PDFAge-, sex-, and height-based blood pressure reference charts, Yazd children 6-18 years, Iran.
Clin Exp Pediatr
August 2020
Department of Psychology, Yazd Azad University, Yazd, Iran.
Article Synopsis
- Pediatric hypertension is a critical health issue for children, leading to significant morbidity and mortality among this population.* -
- The study analyzed 1,035 children and adolescents from Yazd, Iran, to assess blood pressure percentiles, linking data to a larger national survey involving 31,000 participants.* -
- Findings provided age- and height-specific blood pressure percentiles, helping to define hypertension in children as measurements above the 95th percentile.*
Prevalence of Abdominal Obesity and Metabolic Syndrome in Children and Adolescents: A Community Based Cross-Sectional Study.
Iran J Public Health
February 2020
Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- - This study examined the prevalence of abdominal obesity and metabolic syndrome in children and adolescents (ages 6-18) in the Yazd Greater Area of Iran during 2016-2017, highlighting a gap in research on these topics in developing countries
- - Researchers included 1,035 participants from both rural and urban districts, measuring various components of metabolic syndrome and using standard anthropometry methods in a cross-sectional design
- - Results showed that 13.2% of boys and 24.7% of girls aged 6-10 had abdominal obesity, while 7.6% of adolescents (9.4% in boys) had metabolic syndrome, with low HDL-cholesterol and abdominal obesity being the most common issues*.
CT Scan Incidental Findings in Head Trauma Patients - Yazd Shahid Rahnemoun Hospital, 2005-2015.
Arch Iran Med
May 2019
Department of Radiology, Shahid Sadooghi University of Medical Sciences, Yazd, Iran.
Background: Incidental findings are presented in radiology reports. Many of these findings do not require further investigation; however, some require further investigation and repeated imaging. The aim of this study was to determine the frequency of incidental findings on CT scans of patients with head trauma from 2005 to 2015.
View Article and Find Full Text PDFThe prevalence, comorbidity and socio-demographic factors of depressive disorder among Iranian children and adolescents: To identify the main predictors of depression.
J Affect Disord
March 2019
Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:
Background: Depressive disorders are a major public health problem in developed and developing countries. Recently, several risk factors have been described for depressive disorders in children and adolescents. The aim of the present study was to identify the main risk factors that can affect the incidence of depression in Iranian children and adolescents.
View Article and Find Full Text PDFTreatment of recurrent pregnancy loss by Levothyroxine in women with high Anti-TPO antibody.
Iran J Reprod Med
July 2012
Department of Obstetrics and Gynecology, Research and Clinical Centre for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Background: Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before twenty weeks of gestation. It is caused by a variety of genetics and non-genetics factors. Thyroid autoimmunity could associate with pregnancy loss.
View Article and Find Full Text PDF